VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
HTFLHeartflow, Inc. Common Stock
$33.64$12.4B
Research
OverviewAnalysis
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist

HTFL logoHeartflow, Inc. Common Stock(HTFL)Earnings, Financials & Key Ratios

HTFL•NASDAQ
Price updated Jun 19, 2026
SectorHealthcareIndustryHealthcare ITSub-IndustryLife Sciences and Precision Medicine Software
AboutHeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases worldwide. Its HeartFlow Platform uses AI and computational fluid dynamics to creates a personalized 3D model of a patient's heart from a single coronary computed tomography angiography, a specialized type of scan that provides detailed images of the heart's arteries. The company's platform provides insights on blood flow, stenosis, and plaque volume and composition by overcoming the limitations of traditional non-invasive imaging tests. The company was founded in 2007 and is headquartered in Mountain View, California.Show more
  • Revenue$176M+39.9%
  • EBITDA-$55M-4.5%
  • Net Income-$117M-21.1%
  • EPS (Diluted)-0.32+79.1%
  • Gross Margin76.8%+2.3%
  • EBITDA Margin-31.52%+25.3%
  • Operating Margin-36.39%+25.2%
  • Net Margin-66.35%+13.4%
  • ROE-38.85%

HTFL Key Insights

Heartflow, Inc. Common Stock (HTFL) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓Company is almost debt free

✗Weaknesses

  • ✗Negative free cash flow
  • ✗Low quality earnings: Net income not backed by cash flow
  • ✗Shares diluted 100.0% in last year
  • ✗Expensive at 41.2x book value

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Get notified when HTFL posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

HTFL Price & Volume

Heartflow, Inc. Common Stock (HTFL) stock price & volume — 10-year historical chart

Loading chart...

HTFL Growth Metrics

Heartflow, Inc. Common Stock (HTFL) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-
5 Years-
3 Years-
TTM-

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM-

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM-

Return on Capital

10 Years-43.78%
5 Years-43.78%
3 Years-43.78%
Last Year-31.86%

HTFL Recent Earnings

Heartflow, Inc. Common Stock (HTFL) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 2/4 qtrs (50%)●Beat Revenue 3/4 qtrs (75%)
Q2 2026Latest
May 14, 2026
Metric
Actual
Est
EPS
$0.16+14.7%
$0.19
Rev
$53M+5.8%
$50M
Q2 2026
Mar 18, 2026
Metric
Actual
Est
EPS
$0.12+29.0%
$0.17
Rev
$49M+5.5%
$47M
Q4 2025
Nov 12, 2025
Metric
Actual
Est
EPS
$0.27-35.0%
$0.20
Rev
$46M-0.1%
$46M
Q4 2025
Sep 19, 2025
Metric
Actual
Est
EPS
$1.46-630.0%
$0.20
Rev
$43M+0.5%
$43M
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMay 14, 2026
$0.16vs $0.19+14.7%
$53Mvs $50M+5.8%
Q2 2026Mar 18, 2026
$0.12vs $0.17+29.0%
$49Mvs $47M+5.5%
Q4 2025Nov 12, 2025
$0.27vs $0.20-35.0%
$46Mvs $46M-0.1%
Q4 2025Sep 19, 2025
$1.46vs $0.20-630.0%
$43Mvs $43M+0.5%
Based on last 4 quarters of dataView full earnings history →

HTFL Peer Comparison

Heartflow, Inc. Common Stock (HTFL) competitors in Life Sciences and Precision Medicine Software — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
Institutional Holdings
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
ISRG logoISRGIntuitive Surgical, Inc.Direct Competitor144.48B406.7851.6920.51%28.15%16.89%0.02
IRTC logoIRTCiRhythm Technologies, Inc.Direct Competitor3.44B104.65-75.2926.24%-3.53%-20.6%4.79
RXRX logoRXRXRecursion Pharmaceuticals, Inc.Direct Competitor1.44B3.23-2.2426.92%-8.44%-54.32%0.07
NVCR logoNVCRNovoCure LimitedDirect Competitor1.62B14.28-11.708.28%-25.66%-50.82%0.85
GEHC logoGEHCGE HealthCare Technologies Inc.Product Competitor28.02B61.5913.544.84%7.54%14.45%0.94
SYK logoSYKStryker CorporationProduct Competitor117.88B307.8036.6411.16%12.92%15.04%0.66
BSX logoBSXBoston Scientific CorporationProduct Competitor67.31B45.2923.3519.87%14.4%12.4%0.51
ABT logoABTAbbott LaboratoriesProduct Competitor153.68B88.3811.574.59%31.88%27.26%0.32

Compare HTFL vs Peers

Heartflow, Inc. Common Stock (HTFL) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs ISRG

Most directly comparable listed peer for HTFL.

Scale Benchmark

vs NVDA

Larger-name benchmark to compare HTFL against a more recognizable public peer.

Peer Set

Compare Top 5

vs ISRG, IRTC, RXRX, NVCR

HTFL Income Statement

Heartflow, Inc. Common Stock (HTFL) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
MetricDec'23Dec'24Dec'25TTM
Sales/Revenue
87.17M125.81M176.03M191.42M
Revenue Growth %
-44.32%39.92%-
Cost of Goods Sold
29.12M31.36M40.84M42M
COGS % of Revenue
33.41%24.93%23.2%-
Gross Profit
58.05M▲ 0%
94.45M▲ 62.7%
135.2M▲ 43.1%
149.42M▲ 0%
Gross Margin %
66.59%75.07%76.8%78.06%
Gross Profit Growth %
-62.7%43.14%-
Operating Expenses
130.97M155.67M199.26M218.01M
OpEx % of Revenue
150.23%123.74%113.2%-
Selling, General & Admin
95.11M112.15M134.34M145.39M
SG&A % of Revenue
109.1%89.15%76.32%-
Research & Development
35.85M43.52M64.92M72.61M
R&D % of Revenue
41.13%34.59%36.88%-
Other Operating Expenses
0000
Operating Income
-72.91M▲ 0%
-61.22M▲ 16.0%
-64.07M▼ 4.6%
-68.59M▲ 0%
Operating Margin %
-83.64%-48.66%-36.39%-35.83%
Operating Income Growth %
-16.04%-4.65%-
EBITDA
-65.33M-53.09M-55.49M-59.67M
EBITDA Margin %
-74.94%-42.2%-31.52%-31.17%
EBITDA Growth %
-18.73%-4.53%-
D&A (Non-Cash Add-back)
7.59M8.13M8.57M8.91M
EBIT
-70.41M-73.61M-101.69M-96.46M
Net Interest Income
-19.24M-18.7M-9.63M-2.62M
Interest Income
5.46M4.07M5.54M7.46M
Interest Expense
24.69M22.77M15.17M10.08M
Other Income/Expense
-22.19M-35.15M-52.8M-43.29M
Pretax Income
-95.11M▲ 0%
-96.37M▼ 1.3%
-116.87M▼ 21.3%
-111.88M▲ 0%
Pretax Margin %
-109.1%-76.6%-66.39%-58.45%
Income Tax
547K53K-76K-53K
Effective Tax Rate %
-0.58%-0.05%0.07%0.05%
Net Income
-95.66M▲ 0%
-96.43M▼ 0.8%
-116.79M▼ 21.1%
-111.83M▲ 0%
Net Margin %
-109.73%-76.65%-66.35%-58.42%
Net Income Growth %
--0.81%-21.12%-
Net Income (Continuing)
-95.66M-96.43M-116.79M-111.83M
Discontinued Operations
0000
Minority Interest
0000
EPS (Diluted)
-1.94▲ 0%
-1.53▲ 21.1%
-0.32▲ 79.1%
-0.30▲ 0%
EPS Growth %
-21.13%79.09%-
EPS (Basic)
-1.94-1.53-0.32-
Diluted Shares Outstanding
63.86M63.06M368.54M368.54M
Basic Shares Outstanding
63.86M63.06M368.54M368.54M
Dividend Payout Ratio
----

HTFL Balance Sheet

Heartflow, Inc. Common Stock (HTFL) balance sheet — assets, liabilities & shareholders' equity

MetricDec'23Dec'24Dec'25TTM
Total Current Assets
148.45M82.29M220.2M211.83M
Cash & Short-Term Investments
122.77M51.37M176.79M158.32M
Cash Only
122.77M51.37M44.78M19.67M
Short-Term Investments
00132.01M138.65M
Accounts Receivable
22.5M27.09M29.34M35.53M
Days Sales Outstanding
94.278.660.8459.53
Inventory
0000
Days Inventory Outstanding
----
Other Current Assets
598K812K8.11M17.99M
Total Non-Current Assets
36.6M36.42M139.25M132.19M
Property, Plant & Equipment
22.93M19.96M26.07M24.24M
Fixed Asset Turnover
3.80x6.30x6.75x8.11x
Goodwill
0000
Intangible Assets
7.95M7.77M00
Long-Term Investments
00103.36M204.42M
Other Non-Current Assets
5.72M8.69M9.81M11.38M
Total Assets
185.05M▲ 0%
118.7M▼ 35.9%
359.45M▲ 202.8%
344.02M▲ 0%
Asset Turnover
0.47x1.06x0.49x0.62x
Asset Growth %
--35.85%202.81%289.34%
Total Current Liabilities
32.81M33.6M42.37M38.02M
Accounts Payable
2.89M2.87M3.17M5.75M
Days Payables Outstanding
36.1833.4128.3227.51
Short-Term Debt
0006.38M
Deferred Revenue (Current)
2.11M1.04M627K940K
Other Current Liabilities
3.51M2.45M1.93M25.89M
Current Ratio
4.52x2.45x5.20x5.57x
Quick Ratio
4.52x2.45x5.20x5.57x
Cash Conversion Cycle
---32.01
Total Non-Current Liabilities
929.8M944.58M16.43M20.29M
Long-Term Debt
134.01M136.43M019.97M
Capital Lease Obligations
21.45M18.54M16.13M33.5M
Deferred Tax Liabilities
0000
Other Non-Current Liabilities
774.34M789.62M303K322K
Total Liabilities
962.62M978.19M58.8M58.31M
Total Debt
160.6M160.38M22.05M26.35M
Net Debt
37.83M109.02M-22.72M6.68M
Debt / Equity
--0.07x0.09x
Debt / EBITDA
----0.44x
Net Debt / EBITDA
----0.11x
Interest Coverage
-2.85x-3.23x-6.70x-9.57x
Total Equity
-777.56M▲ 0%
-859.48M▼ 10.5%
300.65M▲ 135.0%
285.72M▲ 0%
Equity Growth %
--10.54%134.98%267.12%
Book Value per Share
-12.18-13.630.820.78
Total Shareholders' Equity
-777.56M-859.48M300.65M285.72M
Common Stock
5K6K85K86K
Retained Earnings
-874.53M-970.96M-1.09B-1.12B
Treasury Stock
0000
Accumulated OCI
-501K-772K-425K-685K
Minority Interest
0000

HTFL Cash Flow Statement

Heartflow, Inc. Common Stock (HTFL) cash flow — operating, investing & free cash flow history

MetricDec'23Dec'24Dec'25TTM
Cash from Operations
-76.43M-69M-54.02M-70.96M
Operating CF Margin %
-87.68%-54.85%-30.69%-
Operating CF Growth %
-9.72%21.71%-104.13%
Net Income
-95.66M-96.43M-116.79M-111.83M
Depreciation & Amortization
7.59M8.13M8.57M8.91M
Stock-Based Compensation
11.87M10.21M13.96M11.47M
Deferred Taxes
0000
Other Non-Cash Items
8.3M19.96M47.89M48.97M
Working Capital Changes
-8.54M-10.88M-7.66M-28.49M
Change in Receivables
-9.35M-3.85M-4.89M-7.47M
Change in Inventory
0000
Change in Payables
-623K-327K218K3.51M
Cash from Investing
-6.11M-4.36M-238.57M-238.89M
Capital Expenditures
-6.11M-4.36M-5.03M-5.81M
CapEx % of Revenue
7%3.46%2.85%3.04%
Acquisitions
0000
Investments
----
Other Investing
0000
Cash from Financing
169.32M2.24M286.04M219.28M
Debt Issued (Net)
00-121.9M-73.86M
Equity Issued (Net)
168.73M0408.45M6.63M
Dividends Paid
0000
Share Repurchases
-228K000
Other Financing
589K2.24M-510K286.51M
Net Change in Cash
86.28M▲ 0%
-71.39M▼ 182.7%
-6.74M▲ 90.6%
-90.11M▲ 0%
Free Cash Flow
-82.54M▲ 0%
-73.36M▲ 11.1%
-59.05M▲ 19.5%
-76.77M▲ 0%
FCF Margin %
-94.68%-58.31%-33.54%-40.11%
FCF Growth %
-11.12%19.51%-
FCF per Share
-1.29-1.16-0.16-0.21
FCF Conversion (FCF/Net Income)
0.80x0.72x0.46x0.69x
Interest Paid
20.8M19.16M0-3.44M
Taxes Paid
405K000

HTFL Key Ratios

Heartflow, Inc. Common Stock (HTFL) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric20242025TTM
Return on Equity (ROE)
--38.85%830.46%
Return on Invested Capital (ROIC)
--17.29%95.99%
Gross Margin
75.07%76.8%78.06%
Net Margin
-76.65%-66.35%-58.42%
Debt / Equity
-0.07x0.09x
Interest Coverage
-3.23x-6.70x-9.57x
FCF Conversion
0.72x0.46x0.69x
Revenue Growth
44.32%39.92%-
Related:HTFL Dividend History·HTFL Revenue History·HTFL Price History·HTFL P/E History·HTFL Financial Ratios·HTFL Institutional Holders

HTFL SEC Filings & Documents

Heartflow, Inc. Common Stock (HTFL) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

May 14, 2026·SEC

Material company update

Mar 18, 2026·SEC

Material company update

Jan 12, 2026·SEC

10-K Annual Reports

1
FY 2026

Mar 18, 2026·SEC

10-Q Quarterly Reports

3
FY 2026

May 14, 2026·SEC

FY 2025

Nov 12, 2025·SEC

FY 2025

Sep 19, 2025·SEC

HTFL Frequently Asked Questions

Heartflow, Inc. Common Stock (HTFL) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Heartflow, Inc. Common Stock (HTFL) reported $191.4M in revenue for fiscal year 2025. This represents a 120% increase from $87.2M in 2023.

Heartflow, Inc. Common Stock (HTFL) grew revenue by 39.9% over the past year. This is strong growth.

Heartflow, Inc. Common Stock (HTFL) reported a net loss of $111.8M for fiscal year 2025.

Dividend & Returns

Heartflow, Inc. Common Stock (HTFL) has a return on equity (ROE) of -38.8%. Negative ROE indicates the company is unprofitable.

Heartflow, Inc. Common Stock (HTFL) had negative free cash flow of $76.8M in fiscal year 2025, likely due to heavy capital investments.

What if you invested $1,000 in HTFL back in 2023?

Total return calculator · dividends reinvested · 3+ years of data

See returns →

How much would $100/month in HTFL be worth today?

Dollar cost averaging calculator · DCA vs lump sum

Calculate →